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This thesis deals with problem of tuberculosis. In a theoretical part are summarized 
information and knowledge about tuberculosis, nowadays epidemiology and drugs used in current 
treatment. There are also described drugs in the different stage of clinical trials and could be used 
for treatment of tuberculosis in the future. Searched information were used from accessible 
learning materials and in articles in online databases as Web of Science and PubMed. There are 
also summarized basic methods of computer design of new drugs. 
In practical part of this thesis was focus on novel inhibitor of prolyl-tRNA synthetase, 
which is based on structure of pyrazinamide. There was prepared in silico virtual library of 
pyrazine-based new potential ligands. Related docking to the structure of human prolyl t-RNA 
(pdb: 5VAD) and the bacterial version of this enzyme (pdb: 2J3M) and evaluation was performed 
in Molecular Operating Environment (Chemical Computing Group, Canada). From the results 
were predicted some of the relations between structure and activity. Virtual library of the ligands 
helped prioritize compounds for synthesis. 
In a synthetical part of this thesis were prepared 13 substances with 2 slightly different 
structure types. There were tried 5 synthesis approaches but only 2 were successful. The final 
substances were separated with basic methods to the demanded purity. These compounds were 
confirmed by NMR spectroscopy, infrared spectroscopy and elementary analysis. After that were 
characterized some of the physical properties as melting point. Purified substances were 
submitted for the screening of in vitro antimycobacterial activity. 
Noticed relations between structure and activity were described in this thesis with focus 
on small parts of the molecules and their contribution. Results of the in vitro antimycobacterial 
activity didn’t show any successful derivate. Highest activity on all of the tested species of 
Mycobacteria was 125 µg/ml, which is really low compared to standards. Despite of this results, 
some of the relations between structure and activity were found. According to these results were 
suggested next progress in development of these structures of the compounds.   
